Given that the primary analysis suggested that ANGPTL4 and ANGPTL8 PTVs may reduce triglyceride levels, we tested these PTVs’ impact on type 2 diabetes (T2D), coronary artery disease (CAD) risk in 218,792 individuals from the FinnGen Study. Here, ANGPTL4 is linked to type 2 diabetes mellitus.